Eurogentec – Digital Stand
Eurogentec is an international company founded in 1985, headquartered in Belgium, and part of Kaneka Corp. since 2010.
Eurogentec is recognized as one of the major suppliers in the field of genomics (Oligonucleotides, qPCR kits & reagents) and proteomics (Custom & catalog antibodies and peptides) as well as a trusted US FDA inspected Contract Development and Manufacturing Organization (CDMO) for the production process development and manufacturing of vaccines and medicines (therapeutic oligonucleotides, GMP plasmids, GMP recombinant proteins, mRNA, GMP peptides…).
Eurogentec provides products and services to scientists involved in the life science research, molecular diagnostics and therapeutic development.
Accordingly the company is based on 3 business units:
Research products
Provides a wide range of reagents, kits and consumables for research use such as custom oligonucleotides, high performance PCR/qPCR Kits & Reagents, custom and catalog peptides & antibodies.
Diagnostic Services
Offers technical and project support for contract manufacturing of IVD GMP components (oligonucleotides, DNA polymerases and peptides) for use in molecular diagnostic applications. In addition Eurogentec produces custom pre-dispensed assays and OEM partnership.
Therapeutic manufacturing
Provides a complete gene to injectable service offering. Eurogentec is a US FDA inspected CDMO with high expertise in technology transfer, process development, scale-up and cGMP manufacturing of oligonucleotides, peptides, IVT RNA, proteins, protein conjugates, plasmid DNA and bacterial vaccines for pre-clinical, clinical and commercial uses. Expert in microbial production (E. coli, P. pastoris, etc), Eurogentec offers various development strategies based on protein refolding, periplasmic expression, and protein expression by secretion. As a one-stop shop, Eurogentec provides a complete gene to injectable service offering.
Brochure
Meat the team
Dr Alexi Idiculla
Territory Account Manager
UK
Email: a.idiculla@eurogentec.com
Dr Muriel Craynest
Business Development Manager Therapeutics
Belgium
Email: m.craynest@eurogentec.com
